Henrik Sprengel

Henrik Sprengel is a highly educated individual with an impressive academic background. He studied License en droit at Grenoble University and completed his Lawyer 2nd state exam / bar exam with exceptional results, ranking among the top 4% in Bavaria at Law School Munich. Henrik also holds a Master of Business Administration (MBA) from INSEAD, a Doctor of Law (J.D.) with Cum Laude honors from the University of Bayreuth, a Master of Laws (LL.M.) ranking in the top 2% in Bavaria at LMU Munich, and a Bachelor's degree in Law from Universitat Bayreuth.

In terms of professional experience, Henrik Sprengel has been involved in various organizations in key leadership roles. Currently serving as the Co-Founder & CEO at CanPharma, he previously held the position of Executive Director at Health House International and served as an Advisor at Tangi. Henrik has also been a Co-Founder & CEO at KALAPA Project, Co-Founder at Espronceda - Institute of Art and Culture, Co-founder and MD at LemonGrass Communications, Co-Founder at Grupo HS3, Co-Founder and Advisor at H2A Ventures, Country Manager Spain at PARSHIP GmbH, Founder and Managing Director at EVALO Ltd., International Business Development Executive at Bertelsmann, Head of Ecommerce, Business Development and Legal at dooyoo AG, Trainee at Bain & Company, and Lawyer at Clifford Chance LLP.